Yahoo
NYSE - Nasdaq Real Time Price USD

ResMed Inc. (RMD)

232.46 -20.37 (-8.06%)
As of 1:56:54 PM EDT. Market Open.
Trade ResMed on Coinbase
RMD Q1 2027 earnings call
Replay the call for the latest insights.

Analyst Insights

Top Analyst

Morgan Stanley
58/100
Latest Rating
Equal-Weight

Analyst Price Targets

175.00 Low
251.52 Average
232.46 Current
320.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/30/2026
Analyst Keybanc
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 267 -> 277

Top Analysts

Analyst
Overall Score
Direction Score
Price Score
Latest Rating
Price Target
Date
Morgan Stanley
58
49
81
Equal-Weight
230 2026-06-18
Mizuho
57
51
99
Outperform
220 2026-07-15
Keybanc
52
50
83
Overweight
277 2026-10-31
JP Morgan
42
48
41
Overweight
- 2026-04-15
RBC Capital
38
19
100
Outperform
262 2026-09-15
Citigroup
37
37
14
Neutral
235 2026-07-14
Baird
36
25
100
Neutral
275 2025-12-17
Wells Fargo
36
4
100
Equal-Weight
215 2026-08-07
Piper Sandler
33
3
100
Neutral
225 2026-08-07
Jefferies
33
10
100
Hold
225 2026-07-10
Rows per page
1-10 of 11

Upgrades & Downgrades

Maintains Keybanc: Overweight to Overweight 10/30/2026
Upgrade RBC Capital: Sector Perform to Outperform 9/15/2026
Maintains Keybanc: Overweight to Overweight 8/31/2026
Initiated Rothschild & Co: Neutral 8/19/2026
Maintains RBC Capital: Sector Perform to Sector Perform 8/7/2026
Maintains Piper Sandler: Neutral to Neutral 8/7/2026

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: